ロード中...
ATR/CHK1 inhibitors and cancer therapy
The cell cycle checkpoint proteins ataxia-telangiectasia-mutated-and-Rad3-related kinase (ATR) and its major downstream effector checkpoint kinase 1 (CHK1) prevent the entry of cells with damaged or incompletely replicated DNA into mitosis when the cells are challenged by DNA damaging agents, such a...
保存先:
| 出版年: | Radiother Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856582/ https://ncbi.nlm.nih.gov/pubmed/29054375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2017.09.043 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|